These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29101806)

  • 1. Tetrandrine and cancer - An overview on the molecular approach.
    N B; K R C
    Biomed Pharmacother; 2018 Jan; 97():624-632. PubMed ID: 29101806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapy.
    Liu T; Liu X; Li W
    Oncotarget; 2016 Jun; 7(26):40800-40815. PubMed ID: 27027348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetrandrine and fangchinoline, bisbenzylisoquinoline alkaloids from Stephania tetrandra can reverse multidrug resistance by inhibiting P-glycoprotein activity in multidrug resistant human cancer cells.
    Sun YF; Wink M
    Phytomedicine; 2014; 21(8-9):1110-9. PubMed ID: 24856768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reversing multidrug resistance of epidermoid carcinoma drug-resistant cell line KB-MRP1 by tetrandrine].
    Chen XS; Bao MH; Mei XD
    Ai Zheng; 2007 Aug; 26(8):846-50. PubMed ID: 17697545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy induction enhances tetrandrine-induced apoptosis via the AMPK/mTOR pathway in human bladder cancer cells.
    Kou B; Liu W; Xu X; Yang Y; Yi Q; Guo F; Li J; Zhou J; Kou Q
    Oncol Rep; 2017 Nov; 38(5):3137-3143. PubMed ID: 29048631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo characterizations of tetrandrine on the reversal of P-glycoprotein-mediated drug resistance to paclitaxel.
    Zhu X; Sui M; Fan W
    Anticancer Res; 2005; 25(3B):1953-62. PubMed ID: 16158930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetrandrine--A molecule of wide bioactivity.
    Bhagya N; Chandrashekar KR
    Phytochemistry; 2016 May; 125():5-13. PubMed ID: 26899361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetrandrine isolated from Cyclea peltata induces cytotoxicity and apoptosis through ROS and caspase pathways in breast and pancreatic cancer cells.
    N B; Chandrashekar KR; Prabhu A; Rekha PD
    In Vitro Cell Dev Biol Anim; 2019 May; 55(5):331-340. PubMed ID: 30945115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrandrine induces cell death in SAS human oral cancer cells through caspase activation-dependent apoptosis and LC3-I and LC3-II activation-dependent autophagy.
    Huang AC; Lien JC; Lin MW; Yang JS; Wu PP; Chang SJ; Lai TY
    Int J Oncol; 2013 Aug; 43(2):485-94. PubMed ID: 23695424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of tetrandrine, toremifene and their combination on the reversion of multidrug resistance of K562/A02 cell line].
    Zhao QX; Chen BA; Cheng J; Ding JH; Gao F; Gao C; Sun YY; Wang J; Zhao G; Bao W; Song HH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):61-4. PubMed ID: 18315901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of tetrandrine in cancer therapy.
    Chen YJ
    Acta Pharmacol Sin; 2002 Dec; 23(12):1102-6. PubMed ID: 12466047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with protein kinase inhibitor H89 and Tetrandrine elicits enhanced synergistic antitumor efficacy.
    Yu M; Liu T; Chen Y; Li Y; Li W
    J Exp Clin Cancer Res; 2018 Jun; 37(1):114. PubMed ID: 29866132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetrandrine induces G1/S cell cycle arrest through the ROS/Akt pathway in EOMA cells and inhibits angiogenesis in vivo.
    Xiao W; Jiang Y; Men Q; Yuan L; Huang Z; Liu T; Li W; Liu X
    Int J Oncol; 2015 Jan; 46(1):360-8. PubMed ID: 25355542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrandrine: a review of its anticancer potentials, clinical settings, pharmacokinetics and drug delivery systems.
    Luan F; He X; Zeng N
    J Pharm Pharmacol; 2020 Nov; 72(11):1491-1512. PubMed ID: 32696989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy and cancer: Can tetrandrine be a potent anticancer drug in the near future?
    Bhagya N; Chandrashekar KR
    Biomed Pharmacother; 2022 Apr; 148():112727. PubMed ID: 35219119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance.
    Fu L; Liang Y; Deng L; Ding Y; Chen L; Ye Y; Yang X; Pan Q
    Cancer Chemother Pharmacol; 2004 Apr; 53(4):349-56. PubMed ID: 14666379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic anti-tumour effects of tetrandrine and chloroquine combination therapy in human cancer: a potential antagonistic role for p21.
    Mei L; Chen Y; Wang Z; Wang J; Wan J; Yu C; Liu X; Li W
    Br J Pharmacol; 2015 May; 172(9):2232-45. PubMed ID: 25521075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H1, a derivative of Tetrandrine, exerts anti-MDR activity by initiating intrinsic apoptosis pathway and inhibiting the activation of Erk1/2 and Akt1/2.
    Wei N; Liu GT; Chen XG; Liu Q; Wang FP; Sun H
    Biochem Pharmacol; 2011 Dec; 82(11):1593-603. PubMed ID: 21864508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrandrine inhibits hepatocellular carcinoma cell growth through the caspase pathway and G2/M phase.
    Yu VW; Ho WS
    Oncol Rep; 2013 Jun; 29(6):2205-10. PubMed ID: 23525490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
    Liu ZL; Hirano T; Tanaka S; Onda K; Oka K
    J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.